API, Daj lossis txiv kab ntxwv-daj crystalline hmoov.
Cov mis mos molecular: C15H11BrNNaO3.
Sodium [2-amino-3-(4-bromobenzoyl)phenyl]acetate; 2-Amino-3-(4-bromobenzoyl) phenylacetic acid sodium ntsev; Sodium (2-amino-3-(4-bromobenzoyl)phenyl)acetate; [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid; sodium {2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetate hydrate.
Raws li lub tswv yim tshiab nonsteroidal tshuaj tiv thaiv kab mob, tau ua tiav hauv ophthalmology thiab lwm yam. Nws cov qauv tshuaj tshwj xeeb endows sodium bromophenate nrog muaj zog tiv thaiv kev ua haujlwm thiab cov tshuaj tua kab mob, uas zoo dua li cov tshuaj uas tsis yog tshuaj tiv thaiv kab mob. Tshwj xeeb tshaj yog nyob rau hauv lub teb ntawm ophthalmology, sodium bromide qhov muag tee muaj cov kev kho mob zoo rau inflammatory kab mob ntawm sab nraud thiab anterior lub qhov muag xws li blepharitis thiab conjunctivitis, thiab yog ib qho yooj yim mus use nrog cov neeg mob siab.
Ntxiv nrog rau kev siv tshuaj kho mob ophthalmic, sodium bromophenate tau dav siv los txo ntau yam mob thiab cov tsos mob xws li mob caj dab rheumatoid thiab osteoarthritis, txhim kho lub neej zoo ntawm cov neeg mob. Nws antipyretic thiab platelet aggregation inhibiting teebmeem ua lub luag haujlwm tseem ceeb hauv kev kho mob ntawm ntau yam kab mob. Txawm li cas los xij, zoo li txhua yam tshuaj, kev saib xyuas yuav tsum tau them rau qhov muaj feem cuam tshuam tsis zoo ntawm sodium bromophenate thaum siv
Yog tias muaj kev tsis xis nyob hauv plab hnyuv, los ntshav, thiab lwm yam, cov tshuaj yuav tsum tau siv kom tsim nyog raws li kev qhia ntawm tus kws kho mob.
Zuag qhia tag nrho, sodium bromophenate tau dhau los ua cov khoom lag luam xav tau heev hauv khw muag tshuaj vim nws cov txiaj ntsig zoo thiab kev siv dav dav.
Cim npe nrov: Tuam Tshoj bromfenac sodium manufacturers, lwm tus neeg
